Biostatistics and Biomarkers for the Reliability and Efficiency of Clinical Trials: A Conversation with Dr. Janet Wittes

 

About this Podcast: 

In this episode, Dr. Janet Wittes, Founder and President of WCG Statistics Collaborative sits down with WCG’s President of Patient Advocacy, Steve Smith. Their conversation focuses on the importance of reliability and efficiency in clinical trials, and how biostatisticians work closely with clinicians and patients to help ensure clear results from trials. Moreover, they dive into how biomarkers can serve as surrogate endpoints for a trial, especially in the case of rare disease studies.

About the Author

Steve Smith | President, Patient Advocacy, WCG

Steve Smith is a seasoned patient advocate with an extensive career in software, consulting, process transformation, health care systems and patient-focused drug development. He joined WCG as President Patient Advocacy in 2019 inspired by the incredible value to patients embedded in the wide range of WCG solutions that reduce the time and cost of clinical trials.

Visit Website More Content by Steve Smith | President, Patient Advocacy, WCG
Previous Post
An Inside Look at the Role of Data Monitoring Committees with Dr. Jonathan Seltzer
An Inside Look at the Role of Data Monitoring Committees with Dr. Jonathan Seltzer

Next Post
Dr. Jeffrey Cooper, MD, living with Parkinsons, and expert in clinical trials, on how hard it can be for patients to find clinical trials
Dr. Jeffrey Cooper, MD, living with Parkinsons, and expert in clinical trials, on how hard it can be for patients to find clinical trials